Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
Gafvelin G, Thunberg S, Kronqvist M, Grönlund H, Grönneberg R, Troye-Blomberg M, Akdis M, Fiebig H, Purohit A, Horak F, Reisinger J, Niederberger V, Akdis CA, Cromwell O, Pauli G, Valenta R, van Hage M. Gafvelin G, et al. Among authors: valenta r. Int Arch Allergy Immunol. 2005 Sep;138(1):59-66. doi: 10.1159/000087358. Epub 2005 Aug 11. Int Arch Allergy Immunol. 2005. PMID: 16103688 Clinical Trial.
Molecular determinants of allergen-induced effector cell degranulation.
Gieras A, Focke-Tejkl M, Ball T, Verdino P, Hartl A, Thalhamer J, Valenta R. Gieras A, et al. Among authors: valenta r. J Allergy Clin Immunol. 2007 Feb;119(2):384-90. doi: 10.1016/j.jaci.2006.09.034. Epub 2006 Nov 7. J Allergy Clin Immunol. 2007. PMID: 17291855
Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man.
Pree I, Reisinger J, Focke M, Vrtala S, Pauli G, van Hage M, Cromwell O, Gadermaier E, Egger C, Reider N, Horak F, Valenta R, Niederberger V. Pree I, et al. Among authors: valenta r. J Immunol. 2007 Oct 15;179(8):5309-16. doi: 10.4049/jimmunol.179.8.5309. J Immunol. 2007. PMID: 17911617 Clinical Trial.
A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin.
Westritschnig K, Linhart B, Focke-Tejkl M, Pavkov T, Keller W, Ball T, Mari A, Hartl A, Stöcklinger A, Scheiblhofer S, Thalhamer J, Ferreira F, Vieths S, Vogel L, Böhm A, Valent P, Valenta R. Westritschnig K, et al. Among authors: valenta r. J Immunol. 2007 Dec 1;179(11):7624-34. doi: 10.4049/jimmunol.179.11.7624. J Immunol. 2007. PMID: 18025208
721 results